• Drugstore chain CVS Health Corporation (NYSE: CVS) is no longer offering Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine in many of its retail locations, the company told CNBC on Wednesday.

  • According to CVS spokesman Mike DeAngelis, retail locations continue to offer either the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE: PFE) – BioNTech SE (NASDAQ: BNTX) vaccine.

  • DeAngelis said the change was implemented "several weeks ago and helps us manage our vaccine supply across the chain, both in our pharmacies and clinics."

  • He added that the Johnson & Johnson vaccine is still offered at almost 1,000 of its MinuteClinic locations in 25 states and Washington, D.C.

  • The Johnson & Johnson vaccine was touted as a potential game-changer when it was initially authorized, being a single-dose shot, and can be stored at normal refrigerator temperatures.

  • But the vaccine has been beset by production issues and concerns about its effectiveness against the delta variant.

  • Price Action: CVS shares are down 2.4% at $79.63 during the market session on the last check Thursday.

  • Photo by Johaehn from Pixabay

See more from Benzinga

  • Click here for options trades from Benzinga

  • Moderna COVID-19 Shot Is 93% Effective After Six Months Of Second Dose

  • UK Competition And Markets Authority Accuses Pfizer Of Illegal Pricing Of Its Epilepsy Drug

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

(305) 707 0888